Insight Molecular Diagnostics Inc. Repayments of Debt
Insight Molecular Diagnostics Inc. (IMDX) reported Repayments of Debt of $1.32 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2024-04-16
- Insight Molecular Diagnostics Inc. repayments of debt for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. repayments of debt for the quarter ending 2022-09-30 was $575.00K, a 53.33% increase year-over-year.
- Insight Molecular Diagnostics Inc. repayments of debt for the quarter ending 2022-06-30 was $375.00K, a 0.00% change year-over-year.
- Insight Molecular Diagnostics Inc. repayments of debt for the quarter ending 2022-03-31 was $375.00K, a 0.00% change year-over-year.
- Insight Molecular Diagnostics Inc. repayments of debt for fiscal 2022 was $1.32M, a 11.67% decline from fiscal 2021.
- Insight Molecular Diagnostics Inc. repayments of debt for fiscal 2021 was $1.50M, a 300.00% increase from fiscal 2020.
- Insight Molecular Diagnostics Inc. repayments of debt for fiscal 2020 was $375.00K, a 43.78% decline from fiscal 2019.
- Insight Molecular Diagnostics Inc. repayments of debt for fiscal 2019 was $667.00K, a 16.63% decline from fiscal 2018.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $575.00K derived: sum of 2 quarters · filed 2024-04-16 | $950.00K derived: sum of 3 quarters · filed 2024-04-16 | $1.32M 10-K · filed 2024-04-16 |
| 2022-09-30 | $575.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $950.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.32M 10-Q · filed 2023-11-09 | $1.70M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $750.00K 10-Q · filed 2023-08-10 | $1.13M derived: sum of 3 quarters · filed 2023-08-10 | $1.50M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $375.00K 10-Q · filed 2023-05-15 | $750.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.13M derived: sum of 3 quarters · filed 2023-05-15 | $1.50M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $750.00K derived: sum of 2 quarters · filed 2023-04-12 | $1.13M derived: sum of 3 quarters · filed 2023-04-12 | $1.50M 10-K · filed 2023-04-12 |
| 2021-09-30 | $375.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $750.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.13M 10-Q · filed 2022-11-10 | $1.38M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $750.00K 10-Q · filed 2022-08-12 | $1.00M derived: sum of 3 quarters · filed 2022-08-12 | $1.00M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $375.00K 10-Q · filed 2022-05-12 | $625.00K derived: sum of 2 quarters · filed 2022-05-12 | $625.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $250.00K derived: sum of 2 quarters · filed 2022-03-11 | $375.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $125.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $125.00K 10-Q · filed 2021-08-11 | |||
| 2019-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $267.00K derived: sum of 2 quarters · filed 2020-11-12 | $467.00K derived: sum of 3 quarters · filed 2020-11-12 | $667.00K 10-K · filed 2020-03-26 |
| 2019-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $400.00K derived: sum of 2 quarters · filed 2020-11-12 | $600.00K 10-Q · filed 2020-11-12 | $800.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $400.00K 10-Q · filed 2020-07-29 | $600.00K derived: sum of 3 quarters · filed 2020-07-29 | $800.00K derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | $200.00K 10-Q · filed 2020-05-12 | $400.00K derived: sum of 2 quarters · filed 2020-05-12 | $600.00K derived: sum of 3 quarters · filed 2020-05-12 | $800.00K derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $400.00K derived: sum of 2 quarters · filed 2020-03-26 | $600.00K derived: sum of 3 quarters · filed 2020-03-26 | $800.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $400.00K derived: sum of 2 quarters · filed 2019-11-14 | $600.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $400.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $200.00K 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | $133.00K 10-K · filed 2019-04-01 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |